The VariantPlex Expanded Solid Tumor panel is a targeted next-generation sequencing (NGS) assay that simultaneously detects and characterizes copy number variations (CNVs), single-nucleotide variants (SNVs), insertions and deletions (indels), and microsatellite instability (MSI) status in 76 cancer-implicated genes, including non-small cell lung cancer, colorectal cancer, breast cancer, bladder cancer, pancreatic cancer, prostate cancer, cholangiocarcinoma and melanoma. Thoughtfully designed based on guidelines, literature, and customer input, this recently expanded panel offers sensitive variant detection even with low sample input.